EUXS:LSE:LSE-iShares MSCI Europe Ex UK GBP (GBX)

ETF | Others |

Last Closing

USD 795.85

Change

+0.65 (+0.08)%

Market Cap

USD 0.16B

Volume

0.05M

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-02-25 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
0R1O:LSE Amazon.com Inc.

-4.00 (-1.86%)

USD 1,607.29B
0R1I:LSE NVIDIA Corp.

-7.31 (-5.47%)

USD 618.20B
LCJP:LSE Lyxor Core MSCI Japan (DR) UCI..

+0.05 (+0.31%)

USD 588.35B
LCJD:LSE Amundi MSCI Japan (DR) UCITS E..

+0.10 (+0.54%)

USD 588.35B
0R1G:LSE Home Depot Inc.

N/A

USD 373.16B
0QZK:LSE Coca-Cola Co.

+0.70 (+0.99%)

USD 266.08B
PRJU:LSE Amundi Index Solutions - Amund..

+0.16 (+0.54%)

USD 260.39B
0QZO:LSE 0QZO

-0.30 (-0.27%)

USD 258.54B
0QZ3:LSE Qualcomm Inc.

-2.89 (-1.76%)

USD 202.26B
0R24:LSE Intel Corp.

-1.31 (-5.34%)

USD 196.14B

ETFs Containing EUXS:LSE

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 10.67% 91% A- 83% B
Dividend Return 0.00% 1% F 1% F
Total Return 10.67% 90% A- 83% B
Trailing 12 Months  
Capital Gain 12.17% 64% D 64% D
Dividend Return 0.02% 16% F 14% F
Total Return 12.19% 63% D 63% D
Trailing 5 Years  
Capital Gain 51.14% 62% D 71% C-
Dividend Return 0.12% 17% F 26% F
Total Return 51.27% 60% D- 69% C-
Average Annual (5 Year Horizon)  
Capital Gain 10.65% 63% D 67% D+
Dividend Return 10.74% 62% D 66% D+
Total Return 0.09% 34% F 32% F
Risk Return Profile  
Volatility (Standard Deviation) 14.17% 51% F 68% D+
Risk Adjusted Return 75.78% 73% C 84% B
Market Capitalization 0.16B 55% F 31% F

Annual Financials (GBX)

Quarterly Financials (GBX)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.